Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

XRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

XRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

XORTX Therapeutics Inc.(XRTX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

XORTX Therapeutics Inc.(XRTX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(9)

Expand
  • 20-FFY 2025ended 31 Dec 202520 Mar
  • 20-FFY 2024ended 31 Dec 202412 May 2025
  • NT 20-FFY 2024ended 31 Dec 20241 May 2025
  • 20-FFY 2023ended 31 Dec 202310 May 2024
  • 20-FFY 2022ended 31 Dec 202228 Apr 2023
  • 20-F/AFY 2021ended 31 Dec 202127 Jan 2023
  • 20-FFY 2021ended 31 Dec 20213 May 2022
  • NT 20-FFY 2021ended 31 Dec 20213 May 2022
  • NT 20-FFY 2023ended 31 Dec 202331 Dec 2023

Events(182)

Expand
  • 6-KCurrent report (foreign private issuer)04:58PM
  • 6-KCurrent report (foreign private issuer)8 Oct
  • 6-KCurrent report (foreign private issuer)18 Sep
  • 6-KCurrent report (foreign private issuer)10 Sep
  • 6-KCurrent report (foreign private issuer)9 Sep
  • 6-KCurrent report (foreign private issuer)4 Sep
  • 6-KCurrent report (foreign private issuer)28 Aug
  • 6-KCurrent report (foreign private issuer)17 Aug
  • 6-KCurrent report (foreign private issuer)3 Aug
  • 6-KCurrent report (foreign private issuer)29 Jul
  • 6-KCurrent report (foreign private issuer)15 Jun
  • 6-KCurrent report (foreign private issuer)12 Jun
  • 6-KCurrent report (foreign private issuer)19 May
  • 6-KCurrent report (foreign private issuer)18 May
  • 6-KCurrent report (foreign private issuer)14 May

Beneficial Ownership(5)

Expand
  • SC 13GXORTX Therapeutics Inc.27 Oct 2025
  • SC 13G/AXORTX Therapeutics Inc.15 May 2025
  • SC 13GXORTX Therapeutics Inc.14 Feb 2025
  • SC 13G/AXORTX Therapeutics Inc.14 Feb 2024
  • SC 13GXORTX Therapeutics Inc.14 Feb 2023

Registrations(59)

Expand
  • 424B4Prospectus filing (Rule 424(b)(4))15 May
  • POS AMPost-effective amendment (unspecified)8 May
  • POS AMPost-effective amendment (unspecified)23 Apr
  • POS AMPost-effective amendment (unspecified)21 Apr
  • F-1/ARegistration statement (foreign issuer, amendment)12 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))23 Oct 2025
  • F-1Registration statement (foreign issuer)25 Sep 2025
  • DRSDraft registration statement30 Jul 2025
  • 424B5Prospectus filing (Rule 424(b)(5))13 Dec 2024
  • 424B3Prospectus filing (Rule 424(b)(3))22 Nov 2024
  • 424B3Prospectus filing (Rule 424(b)(3))22 Nov 2024
  • F-1Registration statement (foreign issuer)15 Nov 2024
  • 424B5Prospectus filing (Rule 424(b)(5))18 Oct 2024
  • 424B5Prospectus filing (Rule 424(b)(5))17 Oct 2024
  • 424B3Prospectus filing (Rule 424(b)(3))24 Sep 2024

Filing Review Correspondence(16)

Expand
  • CORRESPFiling review correspondence12 Feb
  • CORRESPFiling review correspondence22 Nov 2024
  • CORRESPFiling review correspondence1 Feb 2023
  • CORRESPFiling review correspondence22 Sep 2022
  • CORRESPFiling review correspondence22 Sep 2022
  • CORRESPFiling review correspondence21 Sep 2022
  • CORRESPFiling review correspondence19 Sep 2022
  • CORRESPFiling review correspondence19 Sep 2022
  • CORRESPFiling review correspondence14 Sep 2022
  • CORRESPFiling review correspondence8 Sep 2022
  • CORRESPFiling review correspondence8 Sep 2022
  • CORRESPFiling review correspondence8 Oct 2021
  • CORRESPFiling review correspondence8 Oct 2021
  • CORRESPFiling review correspondence16 Sep 2021
  • CORRESPFiling review correspondence11 Aug 2021

SEC Orders And Notices(9)

Expand
  • EFFECTNotice of effectiveness14 May
  • EFFECTNotice of effectiveness18 Feb
  • EFFECTNotice of effectiveness7 Aug 2023
  • EFFECTNotice of effectiveness7 Aug 2023
  • EFFECTNotice of effectiveness3 Feb 2023
  • EFFECTNotice of effectiveness30 Sep 2022
  • EFFECTNotice of effectiveness22 Sep 2022
  • EFFECTNotice of effectiveness12 Oct 2021
  • EFFECTNotice of effectiveness

Exempt Offerings(2)

Expand
  • D06b31 Oct 2024
  • D06b25 Jan 2018

Other(3)

Expand
  • CERTCERT12 Oct 2021
  • SEC STAFF LETTERSEC STAFF LETTER12 Oct 2021
  • SEC STAFF LETTERSEC STAFF LETTER13 Aug 2021

Financials(9)

Expand
  • 20-FFY 2025ended 31 Dec 202520 Mar
  • 20-FFY 2024ended 31 Dec 202412 May 2025
  • NT 20-FFY 2024ended 31 Dec 20241 May 2025
  • 20-FFY 2023ended 31 Dec 202310 May 2024
  • 20-FFY 2022ended 31 Dec 202228 Apr 2023
  • 20-F/AFY 2021ended 31 Dec 202127 Jan 2023
  • 20-FFY 2021ended 31 Dec 20213 May 2022
  • NT 20-FFY 2021ended 31 Dec 20213 May 2022
  • NT 20-FFY 2023ended 31 Dec 202331 Dec 2023

Events(182)

Expand
  • 6-KCurrent report (foreign private issuer)04:58PM
  • 6-KCurrent report (foreign private issuer)8 Oct
  • 6-KCurrent report (foreign private issuer)18 Sep
  • 6-KCurrent report (foreign private issuer)10 Sep
  • 6-KCurrent report (foreign private issuer)9 Sep
  • 6-KCurrent report (foreign private issuer)4 Sep
  • 6-KCurrent report (foreign private issuer)28 Aug
  • 6-KCurrent report (foreign private issuer)17 Aug
  • 6-KCurrent report (foreign private issuer)3 Aug
  • 6-KCurrent report (foreign private issuer)29 Jul
  • 6-KCurrent report (foreign private issuer)15 Jun
  • 6-KCurrent report (foreign private issuer)12 Jun
  • 6-KCurrent report (foreign private issuer)19 May
  • 6-KCurrent report (foreign private issuer)18 May
  • 6-KCurrent report (foreign private issuer)14 May

Beneficial Ownership(5)

Expand
  • SC 13GXORTX Therapeutics Inc.27 Oct 2025
  • SC 13G/AXORTX Therapeutics Inc.15 May 2025
  • SC 13GXORTX Therapeutics Inc.14 Feb 2025
  • SC 13G/AXORTX Therapeutics Inc.14 Feb 2024
  • SC 13GXORTX Therapeutics Inc.14 Feb 2023

Registrations(59)

Expand
  • 424B4Prospectus filing (Rule 424(b)(4))15 May
  • POS AMPost-effective amendment (unspecified)8 May
  • POS AMPost-effective amendment (unspecified)23 Apr
  • POS AMPost-effective amendment (unspecified)21 Apr
  • F-1/ARegistration statement (foreign issuer, amendment)12 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))23 Oct 2025
  • F-1Registration statement (foreign issuer)25 Sep 2025
  • DRSDraft registration statement30 Jul 2025
  • 424B5Prospectus filing (Rule 424(b)(5))13 Dec 2024
  • 424B3Prospectus filing (Rule 424(b)(3))22 Nov 2024
  • 424B3Prospectus filing (Rule 424(b)(3))22 Nov 2024
  • F-1Registration statement (foreign issuer)15 Nov 2024
  • 424B5Prospectus filing (Rule 424(b)(5))18 Oct 2024
  • 424B5Prospectus filing (Rule 424(b)(5))17 Oct 2024
  • 424B3Prospectus filing (Rule 424(b)(3))24 Sep 2024

Filing Review Correspondence(16)

Expand
  • CORRESPFiling review correspondence12 Feb
  • CORRESPFiling review correspondence22 Nov 2024
  • CORRESPFiling review correspondence1 Feb 2023
  • CORRESPFiling review correspondence22 Sep 2022
  • CORRESPFiling review correspondence22 Sep 2022
  • CORRESPFiling review correspondence21 Sep 2022
  • CORRESPFiling review correspondence19 Sep 2022
  • CORRESPFiling review correspondence19 Sep 2022
  • CORRESPFiling review correspondence14 Sep 2022
  • CORRESPFiling review correspondence8 Sep 2022
  • CORRESPFiling review correspondence8 Sep 2022
  • CORRESPFiling review correspondence8 Oct 2021
  • CORRESPFiling review correspondence8 Oct 2021
  • CORRESPFiling review correspondence16 Sep 2021
  • CORRESPFiling review correspondence11 Aug 2021

SEC Orders And Notices(9)

Expand
  • EFFECTNotice of effectiveness14 May
  • EFFECTNotice of effectiveness18 Feb
  • EFFECTNotice of effectiveness7 Aug 2023
  • EFFECTNotice of effectiveness7 Aug 2023
  • EFFECTNotice of effectiveness3 Feb 2023
  • EFFECTNotice of effectiveness30 Sep 2022
  • EFFECTNotice of effectiveness22 Sep 2022
  • EFFECTNotice of effectiveness12 Oct 2021
  • EFFECTNotice of effectiveness

Exempt Offerings(2)

Expand
  • D06b31 Oct 2024
  • D06b25 Jan 2018

Other(3)

Expand
  • CERTCERT12 Oct 2021
  • SEC STAFF LETTERSEC STAFF LETTER12 Oct 2021
  • SEC STAFF LETTERSEC STAFF LETTER13 Aug 2021